- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04374643
Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population (PsyConfPop)
Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop
Quarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms.
From March 17th, 2020 to May 11th 2002, the French government has implemented national containment measures due to the Covid-19 epidemic.
Although there are data on the psychological impact and experience of quarantine measures in people who have been infected or suspected of being carriers of certain pathogens (e.g. Ebola), there are no data on such impact in the French population and quarantines lasting longer than 21 days. Investigators therefore propose to conduct a human and social sciences study in order to better understand the current situation
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The main objective is to describe the psychological state during confinement (and the impact of the confinement) in a sample of the French general population.
Secondary objectives :
- to assess the evolution of psychological health between the period of confinement and post-confinement.
- to identify clinical factors modulating psychological state during confinement
It is expected to highlight :
- a link between the intensity of anxiety symptoms and the number/quality of social contacts
- a reduction of anxiety and depression symptoms in the post-confinement period.
- higher consumption of drugs during the confinement period
Self-questionnaires (Google form format) are sent by mailing lists or social networks to participants in order to complete the assessment of psychological state. A unique identifier is sent in a separate email. These assessments are performed at least once during the confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3 and 6 months after the lifting of the confinement because of the risk of developing anxiodepressive symptoms, in particular post-traumatic stressors.
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienorte
-
-
-
Montpellier, Frankreich, 34295
- Rekrutierung
- University Hospital
-
Kontakt:
- Catherine GENTY, MD
- Telefonnummer: +33 4 67 99 61 45 75
- E-Mail: c-genty@chu-montpellier.fr
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion criteria:
- age> 18
Exclusion criteria:
- protective measure (curatorship, guardianship)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
---|---|
Confined patients
General population
|
Questionnaires to assess the psychological impact of confinement and its evolution over 6 months
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Depressive Symptomatology
Zeitfenster: during confinement
|
depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -> min : 0 max : 27)
|
during confinement
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Depressive Symptomatology
Zeitfenster: post-confinement : 15 days, 3 months, 6 months
|
depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -> min : 0 max : 27)
|
post-confinement : 15 days, 3 months, 6 months
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Psychological pain
Zeitfenster: during confinement
|
Psychological pain : likert scale (higher score, more psychological pain-> min : 0 max : 10)
|
during confinement
|
sleep
Zeitfenster: during confinement
|
quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -> min : 0 max : 28)
|
during confinement
|
sleep
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -> min : 0 max : 28)
|
post-confinement (15 days, 3 months, 6 months)
|
anxiety
Zeitfenster: during confinement
|
anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -> min : 0 max : 21)
|
during confinement
|
anxiety
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -> min : 0 max : 21)
|
post-confinement (15 days, 3 months, 6 months)
|
psychological pain
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
psychological pain : likert scale (higher score, more psychological pain-> min : 0 max : 10)
|
post-confinement (15 days, 3 months, 6 months)
|
physical pain
Zeitfenster: during confinement
|
psychological pain : likert scale (higher score, more psychological pain-> min : 0 max : 10)
|
during confinement
|
physical pain
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
psychological pain : likert scale higher score, more psychological pain-> min : 0 max : 10)
|
post-confinement (15 days, 3 months, 6 months)
|
anger
Zeitfenster: during confinement
|
staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -> min : 0 max : 50)
|
during confinement
|
anger
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -> min : 0 max : 50)
|
post-confinement (15 days, 3 months, 6 months)
|
Stressful Event Impact
Zeitfenster: during confinement
|
Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -> min : 0 max : 45) ) |
during confinement
|
Stressful Event Impact
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -> min : 0 max : 45)
|
post-confinement (15 days, 3 months, 6 months)
|
Use of psychotropic drugs
Zeitfenster: during confinement
|
Number of patients declaring an increase of psychotropic drug use
|
during confinement
|
Use of psychotropic drugs
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
Number of patients declaring an increase of psychotropic drug use
|
post-confinement (15 days, 3 months, 6 months)
|
Tobacco consumption
Zeitfenster: during confinement
|
Number of patients declaring an increase of tobacco consumption
|
during confinement
|
Tobacco consumption
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
Number of patients declaring an increase of tobacco consumption
|
post-confinement (15 days, 3 months, 6 months)
|
alcohol consumption
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
Number of patients declaring an increase of alcohol consumption
|
post-confinement (15 days, 3 months, 6 months)
|
alcohol consumption
Zeitfenster: confinement
|
Number of patients declaring an increase of alcohol consumption
|
confinement
|
Illicit substances consumption
Zeitfenster: confinement
|
Number of patients declaring an increase of illicit substances consumption
|
confinement
|
Illicit substances consumption
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
Number of patients declaring an increase of illicit substances consumption
|
post-confinement (15 days, 3 months, 6 months)
|
orientation of life
Zeitfenster: confinement
|
Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --> min : 0 max : 24
|
confinement
|
orientation of life
Zeitfenster: post-confinement (15 days, 3 months, 6 months)
|
Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --> min : 0 max : 24
|
post-confinement (15 days, 3 months, 6 months)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Emilie Olie, MD PhD, University Hospital, Montpellier
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- RECHMPL20_0197
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Depression
-
Washington University School of MedicineAbgeschlossenBehandlungsresistente Depression | Altersdepression | Altersdepression | Refraktäre Depression | Therapieresistente DepressionVereinigte Staaten, Kanada
-
Brigham and Women's HospitalRekrutierungDepression | Bipolare Störung | Bipolare Depression | Episode einer Major Depression | Bipolare I-Depression | Bipolare II-DepressionVereinigte Staaten
-
Ludwig-Maximilians - University of MunichAbgeschlossenTherapieresistente Major DepressionDeutschland
-
St Patrick's Hospital, IrelandAbgeschlossenBipolare Depression | Unipolare Depression | Episode einer Major DepressionIrland
-
Stony Brook UniversityRekrutierungDepression; DepressionVereinigte Staaten
-
University Health Network, TorontoAbgeschlossenBipolare Störung | Bipolare Depression | Bipolare I-Depression | Bipolare II-DepressionKanada
-
Paul J. LamotheUnbekanntBehandlungsresistente Depression | Depression,Mexiko
-
University of Dublin, Trinity CollegeRekrutierungBipolare Depression | Unipolare Depression | Episode einer Major DepressionIrland
-
Baylor College of MedicineIcahn School of Medicine at Mount SinaiAbgeschlossenMajor Depression (MDD) | Behandlungsresistente Depression (TRD)Vereinigte Staaten
-
Soterix MedicalNYU Langone HealthAbgeschlossenBehandlungsresistente Depression | Unipolare DepressionVereinigte Staaten